Skip to main content
SpringerLink
Log in

Treatment of Upper Urothelial Cell Carcinoma

  • Chapter
  • First Online:
Management of Urothelial Carcinoma

  • 542 Accesses

Abstract

The gold standard for management of UTUC is radical nephroureterectomy (RNU). However, a large number of patients with UTUC have poor comorbidity and may experience serious complications after RNU. Thus, nephron-sparing treatment has been recently attempted in cases of low risk UTUC, especially in patients with low renal function and poor comorbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73:111.

    Article  Google Scholar 

  2. Matin SF, Margulis V, Kamat A, Wood CG, Grossman HB, Brown GA, et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer. 2010;116:3127–34.

    Article  Google Scholar 

  3. Porten S, Siefker-Radtke AO, Xiao L, Margulis V, Kamat AM, Wood CG, et al. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer. 2014;120:1794–9.

    Article  Google Scholar 

  4. Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, et al. Platinum-based neoadjuvant chemotherapy improves oncological outcomes in patients with locally advanced upper tract urothelial carcinoma. Eur Urol Focus. 2017. https://doi.org/10.1016/j.euf.2017.03.013.

    Article  Google Scholar 

  5. Gayed BA, Thoreson GR, Margulis V. The role of systemic chemotherapy in management of upper tract urothelial cancer. Curr Urol Rep. 2013;14:94–101.

    Article  Google Scholar 

  6. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh urology: expert consult premium edition: enhanced online features and print, 4-volume set. Amsterdam: Elsevier; 2011.

    Google Scholar 

  7. Jones JS, Gill IS, Klein EA, Rackley RR, Ross JH. Operative urology at the Cleveland clinic. Totowa: Humana Press; 2006.

    Google Scholar 

  8. Ariane MM, Colin P, Ouzzane A, Pignot G, Audouin M, Cornu JN, et al. Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study. Ann Surg Oncol. 2012;19:301–8.

    Article  Google Scholar 

  9. Adibi M, Youssef R, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, et al. Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades. Int J Urol. 2012;19:1060–6.

    Article  Google Scholar 

  10. Roupret M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E, et al. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology. 2007;69:656–61.

    Article  Google Scholar 

  11. Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, et al. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol. 2009;56:1–9.

    Article  Google Scholar 

  12. Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol. 2009;56:520–6.

    Article  Google Scholar 

  13. Hu JC, Silletti JP, Williams SB. Initial experience with robot-assisted minimally-invasive nephroureterectomy. J Endourol. 2008;22:699–704.

    Article  Google Scholar 

  14. Argun OB, Mourmouris P, Tufek I, Tuna MB, Keskin S, Obek C, et al. Radical nephroureterectomy without patient or port repositioning using the Da Vinci Xi robotic system: initial experience. Urology. 2016;92:136–9.

    Article  Google Scholar 

  15. Matin SF, Gill IS. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol. 2005;173:395–400.

    Article  Google Scholar 

  16. Macejko AM, Pazona JF, Loeb S, Kimm S, Nadler RB. Management of distal ureter in laparoscopic nephroureterectomy--a comprehensive review of techniques. Urology. 2008;72:974–81.

    Article  Google Scholar 

  17. Saika T, Nishiguchi J, Tsushima T, Nasu Y, Nagai A, Miyaji Y, et al. Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis. Urology. 2004;63:848–52.

    Article  Google Scholar 

  18. Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62:100–14.

    Article  Google Scholar 

  19. Marshall FF. Laparoscopic radical nephroureterectomy: dilemma of the distal ureter. J Urol. 2005;173:729.

    PubMed  Google Scholar 

  20. Kawauchi A, Fujito A, Ukimura O, Yoneda K, Mizutani Y, Miki T. Hand assisted retroperitoneoscopic nephroureterectomy: comparison with the open procedure. J Urol. 2003;169:890–4. discussion 4.

    Article  Google Scholar 

  21. Gonzalez CM, Batler RA, Schoor RA, Hairston JC, Nadler RB. A novel endoscopic approach towards resection of the distal ureter with surrounding bladder cuff during hand assisted laparoscopic nephroureterectomy. J Urol. 2001;165:483–5.

    Article  CAS  Google Scholar 

  22. Vardi IY, Stern JA, Gonzalez CM, Kimm SY, Nadler RB. Novel technique for management of distal ureter and en block resection of bladder cuff during hand-assisted laparoscopic nephroureterectomy. Urology. 2006;67:89–92.

    Article  Google Scholar 

  23. Gill IS, Soble JJ, Miller SD, Sung GT. A novel technique for management of the en bloc bladder cuff and distal ureter during laparoscopic nephroureterectomy. J Urol. 1999;161:430–4.

    Article  CAS  Google Scholar 

  24. Tae BS, Choi H, Park JY, Bae JH. Laparoscopic approach for intravesical surgery using pneumovesicum in urology: literature review. Int Neurourol J. 2018;22:S10–22.

    Article  Google Scholar 

  25. Cheng CW, Ng CF, Mak SK, Chan SY, Wong YF, Chan CK, et al. Pneumovesicum method in en-Bloc laparoscopic nephroureterectomy with bladder cuff resection for upper-tract urothelial cancer. J Endourol. 2007;21:359–63. discussion 62–3.

    Article  Google Scholar 

  26. Kutikov A, Guzzo TJ, Canter DJ, Casale P. Initial experience with laparoscopic transvesical ureteral reimplantation at the Children’s Hospital of Philadelphia. J Urol. 2006;176:2222–5. discussion 5–6.

    Article  Google Scholar 

  27. Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Nakazawa H, Ito F, et al. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol. 2010;17:848–54.

    Article  Google Scholar 

  28. Moschini M, Foerster B, Abufaraj M, Soria F, Seisen T, Roupret M, et al. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy. World J Urol. 2017;35:1541–7.

    Article  Google Scholar 

  29. Messer J, Lin YK, Raman JD. The role of lymphadenectomy for upper tract urothelial carcinoma. Nat Rev Urol. 2011;8:394–401.

    Article  Google Scholar 

  30. Roscigno M, Brausi M, Heidenreich A, Lotan Y, Margulis V, Shariat SF, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol. 2011;60:776–83.

    Article  Google Scholar 

  31. Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 2009;181:2482–9.

    Article  Google Scholar 

  32. Bolenz C, Shariat SF, Fernandez MI, Margulis V, Lotan Y, Karakiewicz P, et al. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int. 2009;103:302–6.

    Article  Google Scholar 

  33. Komatsu H, Tanabe N, Kubodera S, Maezawa H, Ueno A. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J Urol. 1997;157:1622–4.

    Article  CAS  Google Scholar 

  34. Miyake H, Hara I, Gohji K, Arakawa S, Kamidono S. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. Br J Urol. 1998;82:494–8.

    Article  CAS  Google Scholar 

  35. Roscigno M, Cozzarini C, Bertini R, Scattoni V, Freschi M, Da Pozzo LF, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol. 2008;53:794–802.

    Article  Google Scholar 

  36. Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170:35–41.

    Article  Google Scholar 

  37. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer. 2006;107:2368–74.

    Article  Google Scholar 

  38. Raman JD. Kidney sparing surgery for upper-tract urothelial carcinoma. Minerva Urol Nefrol. 2016;68:359–71.

    PubMed  Google Scholar 

  39. Seisen T, Colin P, Roupret M. Risk-adapted strategy for the kidney-sparing management of upper tract tumours. Nat Rev Urol. 2015;12:155–66.

    Article  Google Scholar 

  40. Clements T, Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, et al. High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol. 2012;26:398–402.

    Article  Google Scholar 

  41. Raman JD, Park R. Endoscopic management of upper-tract urothelial carcinoma. Expert Rev Anticancer Ther. 2017;17:545–54.

    Article  CAS  Google Scholar 

  42. Fang D, Xiong G, Li X, Kang Y, Zhang L, Zhao G, et al. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population. Urol Oncol. 2015;33:66.e1–11.

    Article  Google Scholar 

  43. Auge BK, Pietrow PK, Lallas CD, Raj GV, Santa-Cruz RW, Preminger GM. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol. 2004;18:33–6.

    Article  Google Scholar 

  44. Kleinmann N, Healy KA, Hubosky SG, Margel D, Bibbo M, Bagley DH. Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps. J Endourol. 2013;27:1450–4.

    Article  Google Scholar 

  45. Fiuk JV, Schwartz BF. Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management. World J Nephrol. 2016;5:158–65.

    Article  Google Scholar 

  46. Motamedinia P, Hoenig D, Okeke Z, Smith A. A case for nephron sparing surgery in the management of upper tract urothelial carcinoma. J Endourol. 2016;30(Suppl 1):S18–22.

    Article  Google Scholar 

  47. Suriano F, Brancato T. Nephron-sparing management of upper tract urothelial carcinoma. Rev Urol. 2014;16:21–8.

    PubMed  PubMed Central  Google Scholar 

  48. Audenet F, Traxer O, Bensalah K, Roupret M. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes. World J Urol. 2013;31:45–52.

    Article  Google Scholar 

  49. Thalmann GN, Markwalder R, Walter B, Studer UE. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 2002;168:1381–5.

    Article  Google Scholar 

  50. Irie A, Iwamura M, Kadowaki K, Ohkawa A, Uchida T, Baba S. Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology. 2002;59:53–7.

    Article  Google Scholar 

  51. Schneider B, Thanhauser A, Jocham D, Loppnow H, Vollmer E, Galle J, et al. Specific binding of bacillus Calmette-Guerin to urothelial tumor cells in vitro. World J Urol. 1994;12:337–44.

    Article  CAS  Google Scholar 

  52. Seisen T, Granger B, Colin P, Leon P, Utard G, Renard-Penna R, et al. A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol. 2015;67:1122–33.

    Article  Google Scholar 

  53. Ito A, Shintaku I, Satoh M, Ioritani N, Aizawa M, Tochigi T, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 2013;31:1422–7.

    Article  CAS  Google Scholar 

  54. O'Brien T, Ray E, Singh R, Coker B, Beard R. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol. 2011;60:703–10.

    Article  Google Scholar 

  55. Wu P, Zhu G, Wei D, Liu S, Walsh K, Li D, et al. Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and meta-analysis. J BUON. 2015;20:1229–38.

    PubMed  Google Scholar 

  56. Fang D, Li XS, Xiong GY, Yao L, He ZS, Zhou LQ. Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis. Urol Int. 2013;91:291–6.

    Article  CAS  Google Scholar 

  57. Seisen T, Jindal T, Karabon P, Sood A, Bellmunt J, Roupret M, et al. Efficacy of systemic chemotherapy plus radical nephroureterectomy for metastatic upper tract urothelial carcinoma. Eur Urol. 2017;71:714–8.

    Article  Google Scholar 

  58. Brookland RK, Richter MP. The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol. 1985;133:952–5.

    Article  CAS  Google Scholar 

  59. Catton CN, Warde P, Gospodarowicz MK, Panzarella T, Catton P, McLean M, et al. Transitional cell carcinoma of the renal pelvis and ureter: Outcome and patterns of relapse in patients treated with postoperative radiation. Urol Oncol. 1996;2:171–6.

    Article  CAS  Google Scholar 

  60. Chen B, Zeng ZC, Wang GM, Zhang L, Lin ZM, Sun LA, et al. Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC Cancer. 2011;11:297.

    Article  Google Scholar 

  61. Cozad SC, Smalley SR, Austenfeld M, Noble M, Jennings S, Raymond R. Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology. 1995;46:796–800.

    Article  CAS  Google Scholar 

  62. Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol. 2004;172:1271–5.

    Article  CAS  Google Scholar 

  63. Hall MC, Womack JS, Roehrborn CG, Carmody T, Sagalowsky AI. Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol. 1998;160:703–6.

    Article  CAS  Google Scholar 

  64. Jwa E, Kim YS, Ahn H, Kim CS, Lee JL, Kim SO, et al. Adjuvant radiotherapy for stage III/IV urothelial carcinoma of the upper tract. Anticancer Res. 2014;34:333–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Korea University College of Medicine, Seoul, South Korea

    Bum Sik Tae

  2. Department Urology, Korea University Ansan Hospital, Ansan, South Korea

    Bum Sik Tae

  3. Department Urology, Seoul National University Hospital, Seoul, South Korea

    Chang Wook Jeong

Authors
  1. Bum Sik Tae
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chang Wook Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chang Wook Jeong .

Editor information

Editors and Affiliations

  1. Department of Urology, Seoul National University Hospital, Seoul, Korea (Republic of)

    Ja Hyeon Ku

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tae, B.S., Jeong, C.W. (2019). Treatment of Upper Urothelial Cell Carcinoma. In: Ku, J. (eds) Management of Urothelial Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-10-5502-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5502-7_15

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5501-0

  • Online ISBN: 978-981-10-5502-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation